Résultats de la recherche - 14 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
started in early 2020, many countries and territories were making progress toward hepatitis C virus (HCV) elimination. This study aims to evaluate HCV burden in 2020, and forecast HCV burden by 2030 given ...
Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method
Brussels through respondent driven sampling (RDS). They were considered PWID when they had injected in the last 12 months. Every respondent was invited to a questionnaire and underwent a rapid HCV-test. For ...
Hepatitis C virus prevalence in Belgium
C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...
Hepatitis C virus prevalence in Belgium
C population estimate Seroprevalence Abstract: Reliable hepatitis C prevalence estimates are crucial for a good follow-up of the indicators to eliminate hepatitis by 2030 as set by the World Health Organization. ...
Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.
Lynen; Steven Van Gucht; Benoît Kabamba Mukadi Source: Infect Dis Ther, Volume 9, Issue 3 (2020) Keywords: Genotype Hepatitis C Abstract: INTRODUCTION: We aim to report on results and challenges of ...
Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017.
report, we present the epidemiological trends of symptomatic HEV infections in Belgium, from the distribution by age, sex and geography to the molecular characterisation of the viral strains.MethodSerum ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
to estimate the budgetary impact of reimbursement of direct-acting antivirals (DAA s). In Belgium, the restricted reimbursement criteria are mainly guided by regional seroprevalence estimates of 0.87% ...
Subtype-specific differences in the risk of hospitalisation among patients infected with hepatitis E virus genotype 3 in Belgium, 2010-2018.
established to date. Here, we report that patients infected with HEV-3c were at lower risk of hospitalisation, compared to those infected with HEV-3f, the other main subtype circulating in Belgium. Health ...
Distribution of HCV genotypes in Belgium from 2008 to 2015.
genotypes and subtypes in a country is crucial to guide antiviral therapy and to understand local epidemiology. Studies investigating circulating HCV genotypes and their trends have been conducted in Belgium. ...
Hepatitis E virus serology and PCR: does the methodology matter?
(Altona RealStar®), and two optimized in-house real-time RT- PCR assays (according to Jothikumar et al., 2006 and Gyarmati et al., 2007). In addition, all three PCR assays were performed on 16 external ...